Milne, Jill C <br/><br/>
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.  [electronic resource] 

 -  Nature  Nov 2007 
 - 712-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-4687 
<br/><br/><label>Standard No.: </label>10.1038/nature06261  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Allosteric Site<br/>Animals<br/>Blood Glucose--metabolism<br/>Caloric Restriction<br/>Catalytic Domain<br/>Cell Line<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dietary Fats--administration & dosage<br/>Disease Models, Animal<br/>Drosophila melanogaster<br/>Heterocyclic Compounds, 4 or More Rings--pharmacology<br/>Humans<br/>Insulin--metabolism<br/>Male<br/>Mice<br/>Mitochondria--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Rats, Zucker<br/>Resveratrol<br/>Sirtuin 1<br/>Sirtuins--agonists<br/>Stilbenes--chemistry